Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4

Interventions

Cyclophosphamide 548pembrolizumab 384Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Pancreaticoduodenectomy × Clear all
NCT02517268 2025-04-30

WARP

Thomas Jefferson University

Phase NA Completed
98 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02243358 2023-10-27

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Henry Ford Health System

Phase 2 Completed
24 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01240304 2019-12-10

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

University of Arkansas

Phase 2 Terminated
10 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00766636 2016-05-19

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡